PPT-Factors affecting basal insulin injection adherence investigated using smart insulin pen

Markus Menzen 1 Niels Væver Hartvig 2 Anne Kaas 2 Nikoline Nygård Knudsen 2 Johan Jendle 3 1 Division of Internal Medicine Department of Gastroenterology and Diabetology Community Hospital Bonn Bonn Germany. the Treatment of T1DM and T2DM. Lawrence Blonde, MD, FACP, FACE. Director of the . Ochsner. Diabetes Clinical Research Unit. Ochsner. Medical Center. New Orleans, Louisiana. Vivian . A. Fonseca, MD, FRCP. G. lucose . C. ontrol. Mary Catherine . MacSween. MD FRCPC. The Moncton Hospital . Case DM. 74 year old male DM1 x 40 years.. MDI with . Levemir. 17 units . hs. and . NovoRapid. at meals.. Pre-op instructions take half usual . The Basal Bolus order set is intended for the management of hospitalized patients with poorly controlled blood glucose (greater than 140 mg/. dL. random blood sugar). The Basal Bolus Insulin Order Set. Program Overview. Pathophysiology of Hyperglycemia. Updated ADA/EASD Standard of Care, 2017. Delays in Intensification of Therapy. The Role of Basal Insulin and GLP-1 RA in Controlling Hyperglycemia. Program Goals. The . Incretin System: Response to Oral Glucose. Injected Incretin-based Agents: GLP-1 Receptor Agonists. Oral Incretin-based Agents: DPP-4 Inhibitors . Main Pathophysiological Defects in T2D. GLP-1 RAs in Combination With Basal Insulin Approved by US FDA. Why Combine a GLP-1 RA With Basal Insulin?. Adding Prandial Insulin to Basal Insulin . Exenatide Once Weekly Now Approved for Use With Basal Insulin. August 18, 2017. Disclaimer. This activity features cases that are loosely based on two famous musicians who had diabetes: Jerry Garcia and Ella Fitzgerald. Publicly available medical information was used to construct the core elements of the cases. When information was not available, the activity content planners added relevant, but fictional, details to devise an meaningful educational experience.  . Insulin and Incretins: the perfect Partnership? Stephen Colagiuri, MD Professor of Metabolic Health Boden Institute of Obesity, Nutrition and Exercise University of Sydney Sydney, Australia Moderator Dr. . . Ghadiri. , MD. Assistance professor of endocrinology. Shahid. . Sadoughi. . University of Medical Sciences . 2. The importance of glycemic control in minimizing complications related to diabetes has been well established in type 1 diabetes . Diabetes Educator. Program Coordinator . Diabetes Resource Center . Hopkinsville, KY.. Disclosure. to Participants. Notice of Requirements For Successful Completion. Please refer to learning goals and objectives. FOCUS OF PROFILE GLULISINE. The main target. To normalize . Blood glucose. Delay . progression. Reduce . complication. s. Diabetes Management. ᵛ. ᵛ. fasting. postprandial. 1.Fasting hyperglycemia . I Wear My Pancreas on the Outside: Insulin Pump and CGM Basics. Clinical Dietitian/Certified . D. iabetes . E. ducator. Brody School of Medicine at East Carolina University. Pediatric Specialty Care . Research Institute For Endocrine Sciences. Endocrine Research Center. Shahid Beheshti University. 04.04.1397. Outlines. Case presentation. Barriers of insulin therapy. Action-profile. Types of basal . Insulin Injection and/or. Selected Medications. . SECTION N. MEDICATIONS . January 19, 2016 . 1-3PM. Objectives. Understands this records injections and select medications the resident received during the 7 day look-back period.